Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002042247 | SCV002110827 | uncertain significance | Intellectual disability, autosomal dominant 20 | 2021-07-17 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine with valine at codon 447 of the MEF2C protein (p.Ile447Val). The isoleucine residue is moderately conserved and there is a small physicochemical difference between isoleucine and valine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with MEF2C-related conditions. This variant is not present in population databases (ExAC no frequency). |